{"id":43828,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/opinion-letter-in-house-counsel-debt-securities-under.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"opinion-letter-in-house-counsel-debt-securities-under","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/securities\/opinion-letter-in-house-counsel-debt-securities-under.html","title":{"rendered":"Opinion Letter &#8211; In-House Counsel &#8211; Debt Securities Under Indenture &#8211; UnitedHealth Group Inc."},"content":{"rendered":"<p align=\"right\">9900 Bren Road East<\/p>\n<p align=\"right\">Minnetonka, Minnesota 55343<\/p>\n<p>March 8, 2012<\/p>\n<p>Board of Directors<\/p>\n<p>UnitedHealth Group Incorporated<\/p>\n<p>300 UnitedHealth Group Center<\/p>\n<p>9900 Bren Road East<\/p>\n<p>Minnetonka, Minnesota 55343<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>I have acted as Senior Deputy General Counsel to UnitedHealth Group<br \/>\nIncorporated, a Minnesota corporation (the<br \/>\n&#8220;<strong><em>Company<\/em><\/strong>&#8220;), in connection with the Underwriting<br \/>\nAgreement, dated March 5, 2012 (the &#8220;<strong><em>Underwriting<br \/>\nAgreement<\/em><\/strong>&#8220;), among the Company and Merrill Lynch, Pierce, Fenner<br \/>\n&amp; Smith Incorporated, Barclays Capital Inc., Citigroup Global Markets Inc.<br \/>\nand Credit Suisse Securities (USA) LLC, as representatives (the<br \/>\n&#8220;<strong><em>Representatives<\/em><\/strong>&#8220;) of the several underwriters named<br \/>\nin the Pricing Agreement, dated March 5, 2012 (&#8220;<strong><em>Pricing<br \/>\nAgreement<\/em><\/strong>&#8220;), among the Company and the Representatives, and the<br \/>\nPricing Agreement relating to the proposed issuance by the Company of its 2.875%<br \/>\nNotes due March 15, 2022 in the aggregate principal amount of $600,000,000 (the<br \/>\n&#8220;<strong><em>2022 Notes<\/em><\/strong>&#8220;) and its 4.375% Notes due March 15, 2042<br \/>\nin the aggregate principal amount of $400,000,000 (the &#8220;<strong><em>2042<br \/>\nNotes<\/em><\/strong>&#8221; and collectively with the 2022 Notes, the<br \/>\n&#8220;<strong><em>Debt Securities<\/em><\/strong>&#8220;). The Debt Securities are issuable<br \/>\nunder the Indenture, dated as of February 4, 2008 (the<br \/>\n&#8220;<strong><em>Indenture<\/em><\/strong>&#8220;), between the Company and U.S. Bank<br \/>\nNational Association, as trustee, as supplemented by that certain Officers153<br \/>\nCertificate and Company Order dated March 8, 2012, relating to the 2022 Notes<br \/>\nand that certain Officers153 Certificate and Company Order dated March 8, 2012,<br \/>\nrelating to the 2042 Notes. This opinion letter is furnished to you at your<br \/>\nrequest to enable you to fulfill the requirements of Item 601(b)(5) of<br \/>\nRegulation S-K, 17 C.F.R.  \u00a7 229.601(b)(5), in connection with the Registration<br \/>\nStatement. Capitalized terms used herein and not otherwise defined herein shall<br \/>\nhave the meanings assigned to them in the Underwriting Agreement or the Pricing<br \/>\nAgreement, as applicable.<\/p>\n<p>For purposes of this opinion letter, I, or attorneys in the legal department<br \/>\nof the Company under my direction, have examined copies of such documents and<br \/>\nreviewed such questions of law as I have considered necessary and appropriate<br \/>\nfor the purposes of this opinion.<\/p>\n<p>In rendering the opinions set forth below, I have assumed the genuineness of<br \/>\nall signatures, the accuracy and completeness of all documents submitted to me,<br \/>\nthe authenticity of all original documents, and the conformity to authentic<br \/>\noriginal documents of all documents submitted to me<\/p>\n<hr>\n<p>Board of Directors<\/p>\n<p>UnitedHealth Group Incorporated<\/p>\n<p>Page 2<\/p>\n<p>as copies (including telecopies). I have also assumed the legal capacity for<br \/>\nall purposes relevant hereto of all natural persons and, with respect to all<br \/>\nparties to agreements or instruments relevant hereto other than the Company,<br \/>\nthat such parties had the requisite power and authority (corporate or otherwise)<br \/>\nto execute, deliver and perform such agreements or instruments, that such<br \/>\nagreements or instruments have been duly authorized by all requisite action<br \/>\n(corporate or otherwise), executed and delivered by such parties and that such<br \/>\nagreements or instruments are the valid, binding and enforceable obligations of<br \/>\nall parties thereto. As to questions of fact material to my opinion, I have<br \/>\nrelied upon certificates of officers of the Company and of public officials. I<br \/>\nhave also assumed that any Debt Securities will be issued and sold with such<br \/>\nterms and in such manner as are described in the Registration Statement (as<br \/>\namended from time to time), the Prospectus included therein (as amended from<br \/>\ntime to time) and any related supplements to the Prospectus. This opinion letter<br \/>\nis given, and all statements herein are made, in the context of the foregoing.\n<\/p>\n<p>Based upon, subject to and limited by the foregoing, I am of the opinion<br \/>\nthat:<\/p>\n<table style=\"width: 100%; border-collapse: collapse;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"4%\"><\/td>\n<td width=\"4%\" valign=\"top\">\n<p>(i)<\/p>\n<\/td>\n<td valign=\"top\">\n<p>The Company has the corporate power to issue the Debt Securities and the<br \/>\nCompany has taken all necessary corporate action with respect to such issuance.\n<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/p>\n<table style=\"width: 100%; border-collapse: collapse;\" width=\"100%\" cellpadding=\"0\" class=\" \" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"4%\"><\/td>\n<td width=\"4%\" valign=\"top\">\n<p>(ii)<\/p>\n<\/td>\n<td valign=\"top\">\n<p>The Indenture has been duly authorized, executed and delivered by the<br \/>\nCompany.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>This opinion letter has been prepared for your use in connection with the<br \/>\nRegistration Statement and speaks as of the date hereof. I assume no obligation<br \/>\nto advise you of any changes in the foregoing subsequent to the effective date<br \/>\nof the Registration Statement.<\/p>\n<p>The opinions expressed above are limited to the laws of the State of<br \/>\nMinnesota.<\/p>\n<p>I hereby consent to the filing of this opinion letter as Exhibit 5.1 to a<br \/>\nCurrent Report on Form 8-K of the Company filed with the Securities and Exchange<br \/>\nCommission and thereby incorporated by reference into that Registration<br \/>\nStatement and to the reference to this opinion under the caption &#8220;Legal Matters&#8221;<br \/>\nin the prospectus constituting a part of the Registration Statement. In giving<br \/>\nthis consent, I do not hereby admit that I am an &#8220;expert&#8221; within the meaning of<br \/>\nthe Securities Act of 1933, as amended. Hogan Lovells US LLP may rely on the<br \/>\nopinions expressed in paragraphs (i) and (ii), insofar as they relate to<br \/>\nMinnesota law, for purposes of delivering their legal opinion in connection with<br \/>\nthe validity of the Debt Securities.<\/p>\n<p>Very truly yours,<\/p>\n<p>\/s\/ Kuai H. Leong<\/p>\n<p>Kuai H. Leong<\/p>\n<p>Senior Deputy General Counsel<\/p><\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[9178],"corporate_contracts_industries":[9440],"corporate_contracts_types":[9629,9634],"class_list":["post-43828","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-unitedhealth-group-inc","corporate_contracts_industries-health__plans","corporate_contracts_types-securities","corporate_contracts_types-securities__underwriting"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43828"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43828"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43828"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}